Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPV4 | Q9HBA0 | 2/20 | 0.57 |
| ▸ | DRD3 | P35462 | 6/20 | 0.44 |
| ▸ | DRD2 | P14416 | 5/20 | 0.44 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.41 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.40 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.40 |
| ▸ | ACKR3 | P25106 | 1/20 | 0.40 |
| ▸ | OPRM1 | P35372 | 4/20 | 0.40 |
| ▸ | CCR1 | P32246 | 1/20 | 0.40 |
| ▸ | HTR1A | P08908 | 1/20 | 0.40 |
| ▸ | HTR2A | P28223 | 1/20 | 0.40 |
| ▸ | DRD1 | P21728 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | CCR8 | P51685 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5007939 | 0.92 | TRPV4 (0.60) | TRPV4DRD3DRD2EPHX2SLC6A2 | |
| SCHEMBL5004501 | 0.90 | TRPV4 (0.72) | TRPV4DRD3DRD2EPHX2SLC6A2 | |
| SCHEMBL5007925 | 0.90 | TRPV4 (0.58) | TRPV4DRD3DRD2EPHX2SLC6A2 | |
| SCHEMBL5004473 | 0.87 | TRPV4 (0.54) | TRPV4DRD3DRD2SLC6A2SLC6A4 | |
| SCHEMBL5010207 | 0.85 | TRPV4 (0.57) | TRPV4DRD3DRD2SLC6A2SLC6A4 | |
| SCHEMBL5007972 | 0.85 | TRPV4 (0.54) | TRPV4DRD3DRD2SLC6A2SLC6A4 | |
| SCHEMBL5011594 | 0.83 | TRPV4 (0.54) | TRPV4DRD3DRD2EPHX2SLC6A2 | |
| SCHEMBL5004466 | 0.83 | TRPV4 (0.82) | TRPV4DRD3DRD2EPHX2ACKR3 | |
| SCHEMBL5007984 | 0.83 | TRPV4 (0.55) | TRPV4DRD3DRD2SLC6A2SLC6A4 | |
| SCHEMBL5007235 | 0.81 | TRPV4 (0.48) | TRPV4DRD3DRD2SLC6A2SLC6A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080318945-A1 | Novel Compounds | CASILLAS LINDA N | 2008-12-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080318945-A1 | Novel Compounds | TRPV4, TRPV1, TRPV3 | TRPV4 1/4885DRD3 391/4885DRD2 417/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.